Ophthalmology

SAN DIEGO — Patients with lupus who maintained hydroxychloroquine blood levels of 750 ng/ml to 1,200 ng/ml exhibited 71% to 90% lower risk for high lupus disease activity, according to data presented at ACR Convergence 2023.

In this episode, hosts Laura Enyedi, MD, and Susan MacDonald, MD, sit down and chat with guests Carey Powers, Ali Salo and Tiffany Haynes, to discuss women in leadership, live from the Women in Ophthalmology meeting.

Faricimab is the first and only dual-pathway inhibitor approved for use in ophthalmology; specifically, it is indicated for the treatment of wet age-related macular degeneration and diabetic macular edema.

On this special episode of Rheuminations, I interview comedian and ophthalmologist William Flanary, MD, and Kristin Flanary, also known as the Glaucomfleckens, on hypermobility and physician burnout.

NEWPORT BEACH, Calif. — In this Healio Video Perspective from Octane’s Ophthalmology Tech Forum, Ehsan Sadri, MD, FACS, discusses a panel that looked at the companies serving as disruptive innovators in eye care.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview Steve Schallhorn, MD, Julie Schallhorn, MD, MS, Craig S. Schallhorn, MD, Erin Schallhorn Powers and Eileen Schallhorn.

LAS VEGAS — Between 80% and 85% of optometrists polled during a workshop at Vision Expo West said they have an OCT in their practice, and two-thirds said they have widefield imaging, according to moderator Mark Dunbar, OD, FAAO.

In this edition, macular retinal nerve fiber layer thickness linked with cognitive decline; FDA approves Lucentis biosimilar; advanced visual field loss risk higher after glaucoma diagnosis in Black patients; and more.

In this episode, Jose O. Segura, wealth management advisor and certified business exit planner, discusses establishing objectives within financial planning and organization, how to diversify your portfolio in ever-changing markets and more.

NEW YORK — The gender gap in the authorship of scientific publications persists, but a study found an increase in female first authorship during the COVID-19 pandemic for overall articles and research articles in ophthalmology.